Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.

Juddoo, Vanessa; Juddoo, Sonia; Mégarbane, Bruno

Juddoo, Vanessa; Juddoo, Sonia; Mégarbane, Bruno.

Juddoo V; Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, France.
Juddoo S; Department of Geriatrics, Avicenne Hospital, Bobigny, France.
Mégarbane B; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris University, INSERM UMRS-1144 Paris, France. Electronic address: bruno.megarbane@lrb.aphp.fr.

Vaccine ; 40(19): 2650-2651, 2022 04 26.

Article in English | MEDLINE | ID: covidwho-1764020

Subject(s)

COVID-19; Erythema Nodosum; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; RNA, Messenger/genetics

Keywords

Adverse effect; COVID-19; Erythema nodosum; Vaccine; mRNA

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Erythema Nodosum / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2022 Document Type: Article Affiliation country: J.vaccine.2022.03.052

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google